Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ JNK2 Polyclonal Antibody

Goat Polyclonal Antibody
Supplier: Invitrogen™ PA5142860
This item is not returnable.
View return policy
Description
Additional Information: This antibody is expected to recognize isoforms alpha1, alpha 2. and gamma (NP_620707.1; NP_002743.3; NP_001128516.1). This antibody is tested in Peptide ELISA: antibody detection limit dilution 1:16,000.
MAPK9 (JNK2) is a serine/threonine kinase which plays an important role in the MAPK pathway. JNK2 (p54a, SAPK1a), along with JNK1 and JNK3, is thought to play an important role in nuclear signal transduction through its environmental stress activation and subsequent phosphorylation of the nuclear transcription factor p53.
Specifications
| JNK2 | |
| Polyclonal | |
| Unconjugated | |
| MAPK9 | |
| AI851083; c-Jun kinase 2; c-Jun N-terminal kinase 2; I79_012561; JNK; JNK/SAPK alpha; JNK1; JNK1A2; JNK2; JNK21B1/2; JNK2A; JNK2ALPHA; JNK2B; JNK2BETA; JNK-46; JNK-55; Jun kinase; MAP kinase 10; MAP kinase 8; MAP kinase 9; MAPK 10; MAPK 9; MAPK10; MAPK8; Mapk9; mitogen activated protein kinase 9; mitogen-activated protein kinase 9; OTTHUMP00000161542; OTTHUMP00000161543; p54a; p54-alpha; p54aSAPK; PRKM8; PRKM9; protein kinase, mitogen-activated 9; SAPK; SAPK1; SAPK1a; SAPK1c; SAPK-alpha; stress activated protein kinase alpha II; stress-activated protein kinase 1a; Stress-activated protein kinase JNK2 | |
| Goat | |
| Ammonium sulfate precipitation | |
| RUO | |
| 5601 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| 0.5 mg/mL | |
| TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
| P45984 | |
| MAPK9 | |
| Peptide with sequence ELVKGCVIFQGTDH. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction